Literature DB >> 2517295

Impact of leuprolide acetate on the response to follicular stimulation for in vitro fertilization in patients with normal basal gonadotropin levels.

R G Brzyski1, G S Jones, S Oehninger, A A Acosta, C H Kruithoff, S J Muasher.   

Abstract

Fifteen women with normal basal gonadotropin levels and adequate responses to conventional gonadotropin stimulation for in vitro fertilization (IVF) were pretreated with leuprolide acetate (LA) beginning in the midluteal phase prior to a repeat IVF attempt. A significantly longer duration of stimulation requiring a significantly higher total dosage of gonadotropins was observed in LA cycles. The number of preovulatory oocytes retrieved and preembryos transferred was significantly higher in LA cycles. Six of 15 women (40%) had cryopreservation of supernumerary preembryos in LA cycles, versus none in non-LA cycles; 22% of preovulatory oocytes aspirated in LA cycles were available for cryopreservation for future transfer. Five pregnancies occurred in the 15 LA cycles. IVF patients with normal basal gonadotropin levels and normal responses to conventional gonadotropin stimulation benefit from LA pretreatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2517295     DOI: 10.1007/bf01139184

Source DB:  PubMed          Journal:  J In Vitro Fert Embryo Transf        ISSN: 0740-7769


  13 in total

1.  Pharmacologic hypogonadotropism--an advantage for hMG-induced follicular-maturation and succeeding fertilization.

Authors:  G Bettendorf; W Braendle; C Sprotte; W Poels; W Lichtenberg; C Lindner
Journal:  Horm Metab Res       Date:  1986-09       Impact factor: 2.936

2.  Intraovarian markers of follicular and oocyte maturation.

Authors:  A Pellicer; M P Diamond; A H DeCherney; F Naftolin
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-08

3.  The program for in vitro fertilization at Norfolk.

Authors:  H W Jones; G S Jones; M C Andrews; A Acosta; C Bundren; J Garcia; B Sandow; L Veeck; C Wilkes; J Witmyer; J E Wortham; G Wright
Journal:  Fertil Steril       Date:  1982-07       Impact factor: 7.329

4.  Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization.

Authors:  S Neveu; B Hedon; J Bringer; J M Chinchole; F Arnal; C Humeau; P Cristol; J L Viala
Journal:  Fertil Steril       Date:  1987-04       Impact factor: 7.329

5.  The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome.

Authors:  S J Muasher; S Oehninger; S Simonetti; J Matta; L M Ellis; H C Liu; G S Jones; Z Rosenwaks
Journal:  Fertil Steril       Date:  1988-08       Impact factor: 7.329

6.  The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.

Authors:  S J Muasher; J E Garcia; Z Rosenwaks
Journal:  Fertil Steril       Date:  1985-07       Impact factor: 7.329

7.  Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.

Authors:  K Droesch; S J Muasher; R G Brzyski; G S Jones; S Simonetti; H C Liu; Z Rosenwaks
Journal:  Fertil Steril       Date:  1989-02       Impact factor: 7.329

8.  Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval.

Authors:  D R Meldrum; A Wisot; F Hamilton; A L Gutlay; W F Kempton; D Huynh
Journal:  Fertil Steril       Date:  1989-03       Impact factor: 7.329

9.  Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization.

Authors:  L L Veeck; J W Wortham; J Witmyer; B A Sandow; A A Acosta; J E Garcia; G S Jones; H W Jones
Journal:  Fertil Steril       Date:  1983-05       Impact factor: 7.329

10.  Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles.

Authors:  R Palermo; G Amodeo; D Navot; Z Rosenwaks; E Cittadini
Journal:  Fertil Steril       Date:  1988-02       Impact factor: 7.329

View more
  3 in total

Review 1.  Treatment of low responders.

Authors:  S J Muasher
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

Review 2.  Animal models of transcranial direct current stimulation: Methods and mechanisms.

Authors:  Mark P Jackson; Asif Rahman; Belen Lafon; Gregory Kronberg; Doris Ling; Lucas C Parra; Marom Bikson
Journal:  Clin Neurophysiol       Date:  2016-09-10       Impact factor: 3.708

Review 3.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.